Cellectis SA Receives a Buy from Oppenheimer | Analyst Ratings

Oppenheimer analyst Hartaj Singh maintained a Buy rating on Cellectis SA (NASDAQ: CLLS) yesterday and set a price target of $44. The company’s shares closed yesterday at $30.21.